91³Ô¹Ï
+91-22-40012000
companysecretary@marksanspharma.com
91³Ô¹Ï
Company Profile
From the Chairman's Desk
Vision, Core Values
Milestones
Board of Directors
Management Profile
Mergers & Acquisitions
International Operations
Strategy
Subsidiaries
R&D Capabilities
Quality Policy
World Wide Operations
Formulation Business
Overview
Manufacturing Facilities
Markets
Sample Product Portfolio
Health & Wellness
Consumer Self-Care Products
- OTC
Pain Management
Arthritis
Upper Respiratory
Cough & Cold
Allergy
Digestive Health
VMS
(Vitamins Minerals and Supplements)
Vitamins
Skin Care Products
Hair fall
Prescription
– Rx Therapeutic Segments
Cardiovascular System (CVS)
Central Nervous System (CNS)
Oncology
Anti-Diabetics
Anti-Biotic
R&D
Investor
General Information & Investor Contact
General Information
Composition of Board & Committees
Investor Contact
Materiality of Information
Corporate Announcements
Financial Results
Quarterly Results
Annual Reports
Subsidiary Accounts
Investors Presentation
Earnings Call Transcripts
Compliances
Shareholding Pattern
Corporate Governance
Codes & Policies
Independent Directors
Investors Grievance Report
Shareholders Meeting
Unclaimed Dividend
Shares Liable for Transfer to IEPF
Information for Shareholders
CSR Activities
Others Disclosures
Forms
Newspaper Advertisement
Related Party Transaction
Press Release
ESG Profile
Responsibility
CSR
Sustainability
Media
News
Photo / Video Gallery
Adverse Event
Careers
Overview
Values
Life at Marksans
Contact
General Information & Investor Contact
General Information
Composition of Board & Committees
Investor Contact
Materiality of Information
Corporate Announcements
Financial Results
Quarterly Results
Annual Reports
Subsidiary Accounts
Investors Presentation
Earnings Call Transcripts
Compliances
Shareholding Pattern
Corporate Governance
Codes & Policies
Independent Directors
Investors Grievance Report
Shareholders Meeting
Unclaimed Dividend
Shares Liable for Transfer to IEPF
Information for Shareholders
CSR Activities
Others Disclosures
Forms
Newspaper Advertisement
Related Party Transaction
Press Release
ESG Profile
Investor Relations
Investor Relations
General Information & Investor Contact
Corporate Announcements
Financial Results
Compliances
Press Release
ESG Profile
Home
Investor Relations
Press Release
Press Release
2015
News Release November 2015
News Release August 2015
News Release June 2015
News Release May 2015
News Release February 2015
2014
News Release September 2014
Proceedings of 22nd AGM
Report of the Scrutinizer
Addendum to Notice of 22nd Annual General Meeting
News Release June 14
